Patent classifications
C07K9/00
Method for preparing multiple antigen glycopeptide carbohydrate conjugates
The present invention relates to a method for preparing carbohydrate T cell epitope conjugates of formula (I): M(T-B).sub.n (I) wherein M, T, B and n ore as defined in claim 1.
Method for preparing multiple antigen glycopeptide carbohydrate conjugates
The present invention relates to a method for preparing carbohydrate T cell epitope conjugates of formula (I): M(T-B).sub.n (I) wherein M, T, B and n ore as defined in claim 1.
SUPRAMOLECULAR GLYCOSAMINOGLYCANS
Provided herein are glycosylated peptide amphiphiles (GPAs), supramolecular glyconanostructures assembled therefrom, and methods of use thereof. In particular, provided herein are glycosaminoglycan (GAG) mimetic peptide amphiphiles (PAs) and supramolecular GAG mimetic nanostructures assembled therefrom that mimic the biological activities of GAGs, such as heparin, heparan sulfate, hyaluronic acid etc.
PEPTIDES WITH ANTI-CANCER ACTIVITY
The peptides of the invention are of formula (I) or (IV). The peptides of the invention are useful in the treatment of cancer.
CHILI PEPPER SEED ISOLATED OLIGOPEPTIDE FTLE AND APPLICATION THEREOF IN PREVENTING OR TREATING CANCER
The present disclosure provides an oligopeptide FTLE isolated from chili pepper seeds, and application thereof in preventing or treating cancer, the oligopeptide is isolated from chili pepper seeds and has an anti-tumor effect, and in particular, the oligopeptide can effectively inhibit the growth and metabolism of HepG2 cells, and has a good application prospect.
Electrochemical measurement using phenylenediamine derivative
The present invention addresses the problem of providing a means for making highly sensitive and stable measurements possible using electrochemical measurement methods. This problem is resolved by providing: a labeling substance represented by general formula (1) and used to label a substrate; a measurement substrate that is formed by being labeled using the labeling substance; a method of measuring using electrochemical measurement methods that use the measurement substrate; and a reagent kit that includes as components the labeling substance and/or the measurement substrate. ##STR00001##
(In general formula (1), R.sub.1 is either H or an alkyl group (C.sub.mH.sub.2m+1), m is an integer of 1-4, R.sub.2 is an alkyl group (C.sub.nH.sub.2n+1), and n is an integer of 1-4.)
Electrochemical measurement using phenylenediamine derivative
The present invention addresses the problem of providing a means for making highly sensitive and stable measurements possible using electrochemical measurement methods. This problem is resolved by providing: a labeling substance represented by general formula (1) and used to label a substrate; a measurement substrate that is formed by being labeled using the labeling substance; a method of measuring using electrochemical measurement methods that use the measurement substrate; and a reagent kit that includes as components the labeling substance and/or the measurement substrate. ##STR00001##
(In general formula (1), R.sub.1 is either H or an alkyl group (C.sub.mH.sub.2m+1), m is an integer of 1-4, R.sub.2 is an alkyl group (C.sub.nH.sub.2n+1), and n is an integer of 1-4.)
Antibacterial cell-penetrating peptides
The present disclosure relates to novel antibacterial cell-penetrating peptides and derivatives, and methods to make and use the novel antibacterial cell-penetrating peptides and derivatives. The novel antibacterial cell-penetrating peptides of the present invention with shorter linker between a pyrrolidine ring and a guanidine group provide unexpectedly higher potency against a broader scope of bacterial.
Formulations of vancomycin
Liquid vancomycin containing compositions having extended shelf life are disclosed. The compositions contain vancomycin or a pharmaceutically acceptable salt thereof, a polyol such as glycerol, and lactic acid or a lactate. The compositions are ready to use and easily transferred into larger parenteral solutions prior to administration to patients in need thereof.
Formulations of vancomycin
Liquid vancomycin containing compositions having extended shelf life are disclosed. The compositions contain vancomycin or a pharmaceutically acceptable salt thereof, a polyol such as glycerol, and lactic acid or a lactate. The compositions are ready to use and easily transferred into larger parenteral solutions prior to administration to patients in need thereof.